← Leaderboards
Chadi A. Calarge
University Of Iowa
$13,950,086
Attributed
$14,456,530
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,456,530 · 12
By mechanism
R01$11,721,829 · 4
K23$866,266 · 1
R56$846,528 · 1
R21$840,034 · 2
R03$166,361 · 1
M01$15,512 · 3
Top collaborators
- Sherecce Antoinette Fields2 shared
- Hua Chen1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Peter M Cram$10,602,676
- Janet A. Schlechte$3,052,703
- Lynn C. Richman$2,292,290
- David M. Hasan$9,880,513
- Robert Bruce Wallace$4,552,812
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildAdolescentChildhoodParticipantPharmaceutical PreparationsMaleEnrollmentGrowth17 Year OldYouthSamplingClinically SignificantAge GroupFemalePrevalencePeripheralBone DensityRisperidonePsychopathologyLinkPlayPre-ClinicalMineralsAdult
Grant awards (34)
Using a Large Electronic Health Record Database to Characterize SSRI's Effect on Height Growth$846,528
R56 · FY2025 · HD
Long-term Trajectory of SSRI-Induced Height Growth Suppression$706,698
R01 · FY2025 · HD · contact PI
Long-term Trajectory of SSRI-Induced Height Growth Suppression$707,858
R01 · FY2024 · HD · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders$637,244
R01 · FY2024 · MH · contact PI
Examining the Skeletal Effects of Psychostimulants$632,474
R01 · FY2024 · HD · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders - Administrative Supplement$558,613
R01 · FY2024 · MH · contact PI
Examining the Skeletal Effects of Psychostimulants$642,589
R01 · FY2023 · HD · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders$637,245
R01 · FY2023 · MH · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders$637,245
R01 · FY2022 · MH · contact PI
Examining the Skeletal Effects of Psychostimulants$604,826
R01 · FY2022 · HD · contact PI
Body Iron and Mental Health-Related Outcomes in Adolescents: A NHANES Data Analysis$75,118
R03 · FY2022 · MH · contact PI
Examining the Skeletal Effects of Psychostimulants$665,497
R01 · FY2021 · HD · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders$640,716
R01 · FY2021 · MH · contact PI
Body Iron and Mental Health-Related Outcomes in Adolescents: A NHANES Data Analysis$91,243
R03 · FY2021 · MH · contact PI
Iron Deficiency and Brain Development in Youth with Internalizing Disorders$720,147
R01 · FY2020 · MH · contact PI
Examining the Skeletal Effects of Psychostimulants$713,627
R01 · FY2020 · HD · contact PI
Examining SSRI-Induced Disruption of Pubertal Growth Spurt$236,450
R21 · FY2020 · HD · contact PI
Examining SSRI-Induced Disruption of Pubertal Growth Spurt$203,705
R21 · FY2019 · HD · contact PI
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents$627,965
R01 · FY2014 · MH · contact PI
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents$609,778
R01 · FY2013 · MH · contact PI
Counteracting Risperidone-Induced Hyperprolactinemia in Youths$173,210
K23 · FY2013 · MH · contact PI
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents$643,036
R01 · FY2012 · MH · contact PI
Counteracting Risperidone-Induced Hyperprolactinemia in Youths$173,264
K23 · FY2012 · MH · contact PI
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents$657,258
R01 · FY2011 · MH · contact PI
Counteracting Risperidone-Induced Hyperprolactinemia in Youths$173,264
K23 · FY2011 · MH · contact PI
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents$679,013
R01 · FY2010 · MH · contact PI
Counteracting Risperidone-Induced Hyperprolactinemia in Youths$173,264
K23 · FY2010 · MH · contact PI
Long-Term Safety and Genetic Risk Factors of Risperdone Treatment in Youth$86,945
R21 · FY2010 · MH · contact PI
Counteracting Risperidone-Induced Hyperprolactinemia in Youths$173,264
K23 · FY2009 · MH · contact PI
Long-Term Safety and Genetic Risk Factors of Risperdone Treatment in Youth$97,582
R21 · FY2009 · MH · contact PI
Long-Term Safety and Genetic Risk Factors of Risperdone Treatment in Youth$215,352
R21 · FY2008 · MH · contact PI
METABOLIC AND HORMONAL ABNORMALITIES IN CHILDREN TREATED WITH RISPERIDONE$9,089
M01 · FY2007 · RR · contact PI
EFFECTS OF ARIPIPRAZOLE ON BRAIN MORPHOLOGY IN CONDUCT DISORDER$137
M01 · FY2007 · RR · contact PI
METABOLIC AND HORMONAL ABNORMALITIES IN CHILDREN TREATED WITH RISPERIDONE$6,286
M01 · FY2006 · RR · contact PI